Vishal A Patel
Overview
Explore the profile of Vishal A Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
713
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thakker S, Minkis K, Lipner S, Gulati N, Patel V, Al-Mondhiry J
J Am Acad Dermatol
. 2025 Feb;
PMID: 39955007
No abstract available.
2.
Jairath N, Chennareddy S, Manduca S, Lopez A, Alam M, Golda N, et al.
Clin Exp Dermatol
. 2025 Jan;
PMID: 39823530
No abstract available.
3.
Thakker S, Jaguan D, Belzberg M, Gulati N, Campbell J, DeClerck B, et al.
J Am Acad Dermatol
. 2025 Jan;
PMID: 39793708
This review article focuses on acral lentiginous melanoma (ALM), a rare cutaneous malignancy and the least common subtype of cutaneous malignant melanoma (CMM). ALM exhibits distinct characteristics, such as low...
4.
Jaguan D, Thakker S, Belzberg M, Gulati N, Campbell J, DeClerck B, et al.
J Am Acad Dermatol
. 2025 Jan;
PMID: 39788429
This comprehensive review navigates the clinical management and challenges of acral lentiginous melanoma (ALM), including staging, surgical interventions, and systemic therapies. Multimodality treatment and clinical trials are recommended for advanced...
5.
Asediya V, Anjaria P, Mathakiya R, Koringa P, Nayak J, Bisht D, et al.
Int J Biol Macromol
. 2024 Oct;
282(Pt 1):136643.
PMID: 39426778
The COVID-19 pandemic has underscored the critical importance of effective vaccines, yet their development is a challenging and demanding process. It requires identifying antigens that elicit protective immunity, selecting adjuvants...
6.
Yosef T, Ergete W, Revankar R, Patel H, Kumsa T, Patel V, et al.
JAAD Int
. 2024 Oct;
17:99-103.
PMID: 39399332
Background: Cutaneous squamous cell carcinoma (cSCC) is the most common keratinocyte carcinoma in dark-skinned ethnic groups. Available studies are primarily focused on white populations, with fewer data available for black...
7.
Cheraghlou S, Stevenson M, Christensen S, Bordeaux J, Walker J, Srivastava D, et al.
JAMA Dermatol
. 2024 Jul;
160(9):989-992.
PMID: 39046711
Importance: Cutaneous squamous cell carcinoma (CSCC) is the second most common malignant disease in the US. Although it typically carries a good prognosis, a subset of CSCCs are highly aggressive,...
8.
Berman B, Armstrong A, Lebwohl M, Grada A, Bhatia N, Patel V, et al.
JAAD Int
. 2024 Jul;
16:192-198.
PMID: 39040844
Background: Current assessments on topical treatment attributes in actinic keratosis (AK) do not evaluate safety, effectiveness, and satisfaction from both clinician and patient perspectives, creating an unmet need for more...
9.
Stull C, Clark D, Parker T, Idriss M, Patel V, Migden M
J Am Acad Dermatol
. 2024 Jun;
91(5):910-921.
PMID: 38942173
Immunotherapies have revolutionized the management of advanced cutaneous malignancies. However, some patients fail to respond to these therapies, others are ineligible because of comorbidities, and a minority of patients experience...
10.
Sun K, Liakos W, Patel V
J Drugs Dermatol
. 2024 May;
23(5):e139-e141.
PMID: 38709704
No abstract available.